PortfoliosLab logoPortfoliosLab logo
INSG vs. CRBP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INSG vs. CRBP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inseego Corp. (INSG) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INSG achieves a -14.70% return, which is significantly lower than CRBP's 18.92% return. Over the past 10 years, INSG has outperformed CRBP with an annualized return of -5.79%, while CRBP has yielded a comparatively lower -20.50% annualized return.


INSG

1D
1.86%
1M
-21.01%
6M
-16.01%
YTD
-14.70%
1Y
11.73%
3Y*
7.25%
5Y*
-37.89%
10Y*
-5.79%

CRBP

1D
0.21%
1M
18.19%
6M
16.49%
YTD
18.92%
1Y
17.05%
3Y*
7.01%
5Y*
-28.44%
10Y*
-20.50%
*Multi-year figures are annualized to reflect compound growth (CAGR)

INSG vs. CRBP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
INSG
Inseego Corp.
-14.70%0.10%366.79%-73.91%-85.55%-62.31%111.05%76.63%157.76%-34.02%
CRBP
Corbus Pharmaceuticals Holdings, Inc.
18.92%-31.02%95.36%82.20%-82.05%-50.74%-77.11%-6.51%-17.75%-15.98%

Correlation

The correlation between INSG and CRBP is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2014

0.21

Fundamentals

Market Cap

INSG:

$142.58M

CRBP:

$121.34M

EPS

INSG:

$0.83

CRBP:

-$5.72

Total Revenue (TTM)

INSG:

$168.85M

CRBP:

$0.00

Gross Profit (TTM)

INSG:

$64.27M

CRBP:

-$149.00K

EBITDA (TTM)

INSG:

$22.85M

CRBP:

-$61.36M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

INSG vs. CRBP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INSG
INSG Risk / Return Rank: 5050
Overall Rank
INSG Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
INSG Sortino Ratio Rank: 5252
Sortino Ratio Rank
INSG Omega Ratio Rank: 5151
Omega Ratio Rank
INSG Calmar Ratio Rank: 5050
Calmar Ratio Rank
INSG Martin Ratio Rank: 4949
Martin Ratio Rank

CRBP
CRBP Risk / Return Rank: 5454
Overall Rank
CRBP Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
CRBP Sortino Ratio Rank: 5656
Sortino Ratio Rank
CRBP Omega Ratio Rank: 5858
Omega Ratio Rank
CRBP Calmar Ratio Rank: 5252
Calmar Ratio Rank
CRBP Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INSG vs. CRBP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inseego Corp. (INSG) and Corbus Pharmaceuticals Holdings, Inc. (CRBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


INSGCRBPDifference
Sharpe ratioReturn per unit of total volatility

-0.09

Sortino ratioReturn per unit of downside risk

-0.11

Omega ratioGain probability vs. loss probability

1.09

1.12

-0.03

Calmar ratioReturn relative to maximum drawdown

0.15

0.26

-0.11

Martin ratioReturn relative to average drawdown

0.30

0.36

-0.07

INSG vs. CRBP - Sharpe Ratio Comparison

The current INSG Sharpe Ratio is 0.12, which is lower than the CRBP Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of INSG and CRBP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

INSG vs. CRBP - Drawdown Comparison

The maximum INSG drawdown since its inception was -99.92%, roughly equal to the maximum CRBP drawdown of -99.31%. Use the drawdown chart below to compare losses from any high point for INSG and CRBP.


Loading charts...

Drawdown Indicators


INSGCRBPDifference

Max Drawdown

Largest peak-to-trough decline

-99.92%

-99.31%

-0.61%

Max Drawdown (1Y)

Largest decline over 1 year

-59.68%

-61.88%

+2.20%

Max Drawdown (3Y)

Largest decline over 3 years

-79.31%

-92.01%

+12.70%

Max Drawdown (5Y)

Largest decline over 5 years

-98.05%

-95.46%

-2.59%

Max Drawdown (10Y)

Largest decline over 10 years

-99.13%

-99.31%

+0.18%

Current Drawdown

Current decline from peak

-99.62%

-96.88%

-2.74%

Average Drawdown

Average peak-to-trough decline

-96.27%

-66.25%

-30.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.67%

43.50%

-13.83%

Volatility

INSG vs. CRBP - Volatility Comparison

Inseego Corp. (INSG) has a higher volatility of 17.91% compared to Corbus Pharmaceuticals Holdings, Inc. (CRBP) at 13.19%. This indicates that INSG's price experiences larger fluctuations and is considered to be riskier than CRBP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


INSGCRBPDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.91%

13.19%

+4.72%

Volatility (6M)

Calculated over the trailing 6-month period

59.00%

60.65%

-1.65%

Volatility (1Y)

Calculated over the trailing 1-year period

77.05%

79.15%

-2.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

94.93%

159.12%

-64.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.91%

129.05%

-45.14%

Dividends

INSG vs. CRBP - Dividend Comparison

Neither INSG nor CRBP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INSG vs. CRBP - Financials Comparison

This section allows you to compare key financial metrics between Inseego Corp. and Corbus Pharmaceuticals Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
34.34M
0
(INSG) Total Revenue
(CRBP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


INSG and CRBP have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSG has higher volatility (17.91%) compared to CRBP (13.19%). In terms of maximum drawdown, INSG dropped -99.92% vs CRBP's -99.31%.

CRBP currently has the higher Sharpe Ratio (0.20 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for INSG and CRBP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer